215 related articles for article (PubMed ID: 21406267)
1. Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination.
Parretta E; Ianniello B; Ferrazin F; Rossi F; Capuano A
Vaccine; 2011 May; 29(20):3708-13. PubMed ID: 21406267
[TBL] [Abstract][Full Text] [Related]
2. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.
Vellozzi C; Broder KR; Haber P; Guh A; Nguyen M; Cano M; Lewis P; McNeil MM; Bryant M; Singleton J; Martin D; DeStefano F
Vaccine; 2010 Oct; 28(45):7248-55. PubMed ID: 20850534
[TBL] [Abstract][Full Text] [Related]
3. An early (3-6 weeks) active surveillance study to assess the safety of pandemic influenza vaccine Focetria in a province of Emilia-Romagna region, Italy - part one.
Candela S; Pergolizzi S; Ragni P; Cavuto S; Nobilio L; Di Mario S; Dragosevic V; Groth N; Magrini N;
Vaccine; 2013 Feb; 31(10):1431-7. PubMed ID: 22766247
[TBL] [Abstract][Full Text] [Related]
4. A prospective observational safety study on MF59(®) adjuvanted cell culture-derived vaccine, Celtura(®) during the A/H1N1 (2009) influenza pandemic.
Reynales H; Astudillo P; de Vallière S; Hatz C; Schlagenhauf P; Rath B; Velentgas P; Fariña A; Sales-Carmona V; Groth N
Vaccine; 2012 Oct; 30(45):6436-43. PubMed ID: 22902681
[TBL] [Abstract][Full Text] [Related]
5. Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance.
Kurz X; Domergue F; Slattery J; Segec A; Szmigiel A; Hidalgo-Simon A
Vaccine; 2011 Jun; 29(26):4378-87. PubMed ID: 21501644
[TBL] [Abstract][Full Text] [Related]
6. Impact of prior or concomitant seasonal influenza vaccination on MF59-adjuvanted H1N1v vaccine (Focetria) in adult and elderly subjects.
Gasparini R; Schioppa F; Lattanzi M; Barone M; Casula D; Pellegrini M; Veitch K; Gaitatzis N
Int J Clin Pract; 2010 Mar; 64(4):432-8. PubMed ID: 20039974
[TBL] [Abstract][Full Text] [Related]
7. Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district.
Cristiani C; Tuccori M; Pepe P; Sarteschi A; Maddalo F; Simonini G; Michi P; Consigli V; Fornai M; Antonioli L; Blandizzi C
Vaccine; 2011 Apr; 29(18):3443-8. PubMed ID: 21396903
[TBL] [Abstract][Full Text] [Related]
8. Active surveillance of adverse events following immunization against pandemic influenza A (H1N1) in Korea.
Choe YJ; Cho H; Song KM; Kim JH; Han OP; Kwon YH; Bae GR; Lee HJ; Lee JK
Jpn J Infect Dis; 2011; 64(4):297-303. PubMed ID: 21788704
[TBL] [Abstract][Full Text] [Related]
9. Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations.
Banzhoff A; Haertel S; Praus M
Hum Vaccin; 2011 May; 7(5):539-48. PubMed ID: 21422814
[TBL] [Abstract][Full Text] [Related]
10. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
[TBL] [Abstract][Full Text] [Related]
11. Comparison of half and full doses of an MF59-adjuvanted cell culture-derived A/H1N1v vaccine in Japanese children.
Yasuda Y; Komatsu R; Matsushita K; Minami T; Suehiro Y; Sawata H; Nakura N; Jaeger RK; Lattanzi M
Adv Ther; 2010 Jul; 27(7):444-57. PubMed ID: 20586002
[TBL] [Abstract][Full Text] [Related]
12. Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months.
Esposito S; Pugni L; Daleno C; Ronchi A; Valzano A; Serra D; Mosca F; Principi N
Pediatrics; 2011 May; 127(5):e1161-8. PubMed ID: 21464195
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010.
Folkenberg M; Callréus T; Svanström H; Valentiner-Branth P; Hviid A
Vaccine; 2011 Feb; 29(6):1180-4. PubMed ID: 21172382
[TBL] [Abstract][Full Text] [Related]
14. MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination.
Vesikari T; Groth N; Karvonen A; Borkowski A; Pellegrini M
Vaccine; 2009 Oct; 27(45):6291-5. PubMed ID: 19840662
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.
Roman F; Vaman T; Gerlach B; Markendorf A; Gillard P; Devaster JM
Vaccine; 2010 Feb; 28(7):1740-5. PubMed ID: 20034605
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major.
Esposito S; D'Angelo E; Daleno C; Peia F; Scala A; Serra D; Mirra N; Galeone C; Principi N
Vaccine; 2010 Nov; 28(50):7825-8. PubMed ID: 20888873
[TBL] [Abstract][Full Text] [Related]
17. MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database.
Pellegrini M; Nicolay U; Lindert K; Groth N; Della Cioppa G
Vaccine; 2009 Nov; 27(49):6959-65. PubMed ID: 19751689
[TBL] [Abstract][Full Text] [Related]
18. Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy.
Tsai TF; Crucitti A; Nacci P; Nicolay U; Della Cioppa G; Ferguson J; Clemens R
Scand J Infect Dis; 2011 Sep; 43(9):702-6. PubMed ID: 21534891
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.
Atmar RL; Keitel WA; Patel SM; Katz JM; She D; El Sahly H; Pompey J; Cate TR; Couch RB
Clin Infect Dis; 2006 Nov; 43(9):1135-42. PubMed ID: 17029131
[TBL] [Abstract][Full Text] [Related]
20. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.
Salmon DA; Akhtar A; Mergler MJ; Vannice KS; Izurieta H; Ball R; Lee GM; Vellozzi C; Garman P; Cunningham F; Gellin B; Koh H; Lurie N;
Pediatrics; 2011 May; 127 Suppl 1():S78-86. PubMed ID: 21502251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
